Radiologic Analysis of COVID-19 Infection
In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical,…
Categories:
The challenges of TNM-staging for head and neck tumors - Interview with Prof. Dr. Beer
Next to clinical examination and endoscopy, cross-sectional imaging plays an important role in the diagnosis of head and neck tumors. Moreover, the…
Cincinnati Children's Hospital Medical Center: Study shows variable correlation of change in DIPG tumor size among different measurement strategies
A recent prospective study [1] conducted by researchers at Cincinnati Children’s Hospital Medical Center compared manual 2D, semi-automated 2D, and…
Creating evidence to tackle COVID-19
Our COVID-19 reading template is in use for two weeks, and its usage is multiplying. We are grateful for the close cooperation and feedback from…
Potential of using structured data from clinical trials and routine for AI and radiomics research
Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they…
Mint Medical provides a reading template for the standardized assessment and documentation of COVID-19 disease (coronavirus) based on CT imaging
In the first week of March, we will make the relevant software functions available for all our current users at no cost. We plan to offer the COVID-19…
Mint Medical provides a reading template for the standardized assessment and documentation of COVID-19 disease (coronavirus) based on CT imaging
Heidelberg, GER – Mint Medical GmbH, a global MedTech company specialized in software solutions for data-driven radiology, today announced that it…
Clear, consistent, and complete documentation of imaging-derived information
The radiology report is expected to provide information that impacts life changing treatment decisions at every cancer care step in which imaging is…
Real-world data to enhance clinical trial evidence
In randomized controlled trials (RCTs), a vast proportion of patients does not meet the precise inclusion criteria. In oncology, for example,…